Form D · Pharmaceuticals
AXIAL THERAPEUTICS, INC.
Woburn, MA · CIK 0001691625
Offering snapshot reported Feb 11, 2025 · SEC filing
- Reported sold
- $19.4M Offering amount: $22M
- Investors reported
- 29 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 28, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 11, 2025 | Initial | $19,379,799 | No comparison | 29 | SEC filing |
| Oct 27, 2023 | Initial | $11,054,030 | No comparison | 35 | SEC filing |
| Oct 25, 2021 | Amendment | $27,352,547 | $22,586,851vs May 26, 2021 | 38 | SEC filing |
| May 26, 2021 | Initial | $4,765,696 | No comparison | Not reported | SEC filing |
| May 22, 2020 | Initial | $7,825,000 | No comparison | 21 | SEC filing |
| Jun 24, 2019 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Nov 21, 2018 | Initial | $20,026,439 | No comparison | 36 | SEC filing |
| Jun 29, 2017 | Amendment | $19,150,000 | $9,575,000vs Dec 7, 2016 | 16 | SEC filing |
| Dec 7, 2016 | Initial | $9,575,000 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-537960
Source: Form D, filed Feb 11, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard P. Aldrich | Director |
| Sakae Asanuma | Director |
| James C. Blair | Director |
| Scott C. Brun | Director |
| A. Stewart Campbell | Director, Executive |
| Michele Cucullu | Director |
| Eric De La Fortelle | Director |
| Michelle Dipp | Director |
| David H. Donabedian | Director, Executive |
| Nora Frey | Director |
| Sarkis K. Mazmanian | Director |
| Sarah Meibusch | Director |
| Mark Ohori | Director |
| Ronald C. Renaud Jr. | Director |
| Rebecca Senter | Executive |
| Henry C. Wolf | Director |
| Jeffrey E. Young | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
400 Tradecenter Drive, Suite 6990
Woburn, MA, 01801
Woburn, MA, 01801